The risks of handling cytotoxic drugs
- 1 December 1990
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 12 (6) , 228-235
- https://doi.org/10.1007/bf01967822
Abstract
Presuming that preparation of antineoplastic drugs without proper protection may lead to mutagenic urine (of which the effects are uncertain), one has to take great care when preparing these drugs. Apart from Norway no other country has national regulations issued by the government for handling cytostatic agents. Many organizations in various countries have made their own guidelines, which may be adapted to the situations in local hospitals. The following recommendations have been compiled after a review of the literature. They reflect a personal set of guidelines for preparation, administration and disposal of cytotoxic drugs. They are probably the minimum precautions that should be taken, and have not been approved by any committee or agency. Further precautions must first have their potential benefit weighed against probable inconvenience and additional costs.Keywords
This publication has 101 references indexed in Scilit:
- The risks of handling cytotoxic drugsInternational Journal of Clinical Pharmacy, 1990
- Mutagenicity in urine from nurses handling cytostatic agentsEuropean Journal of Cancer and Clinical Oncology, 1986
- Antineoplastic Drugs and Spontaneous Abortion in NursesNew England Journal of Medicine, 1986
- Hazards to Health Workers from Antineoplastic DrugsNew England Journal of Medicine, 1985
- A Study of Occupational Exposure to Antineoplastic Drugs and Fetal Loss in NursesNew England Journal of Medicine, 1985
- Safety Precautions in Home ChemotherapyThe American Journal of Nursing, 1984
- A Prospective Study of Spontaneous Fetal Losses after Induced AbortionsNew England Journal of Medicine, 1979
- Corneal toxicity from vinblastine solution.British Journal of Ophthalmology, 1978
- Detection of mutagenic activity in human urine using mutant strains of salmonella typhimuriumCancer, 1976
- Cyclophosphamide: Pilot study of genetically active metabolites in the urine of a treated human patient induction of mitotic gene conversions in yeastMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1973